When Hoot creates your physician-recorded patient education content, regulatory and legal compliance is built into every step. FDA pharmacovigilance, MLR review, HIPAA, fair balance, and adverse event reporting are handled by design, not retrofitted after the fact.
The moment a patient receives content about your drug, your commercial team inherits a stack of regulatory obligations. Here is what those are, and what Hoot does about each one.
Patient-reported side effects arrive through SMS and email with no system to capture, classify, or route them for FDA submission.
AE signals flagged automatically. Compiled against MedWatch standards and routed to your medical affairs team before any FDA submission.
MLR review happens once at launch, with no version control, no revision tracking, and no deployment gate tied to approval status.
Full MLR workflow managed by Hoot. Content is version-controlled and deployment is gated on your team's sign-off.
Patient identifiers are transmitted and stored without HIPAA safeguards, BAAs, or US data residency requirements in place.
HIPAA-compliant end to end. BAAs with all subprocessors, encrypted transmission, US-based data residency, and SOC 2 Type II certification.
Fair balance and ISI language is omitted or inconsistently applied across patient-facing video content, creating promotional violations.
Fair balance and ISI included by default. Every branded piece is reviewed against the current label and updated when changes are issued.
Opt-in consent is not documented, opt-out requests are processed manually, and SMS sender identification does not meet TCPA requirements.
Consent captured and stored at point of care. Opt-outs honored automatically. Sender identification meets FTC and FCC requirements.
Content referencing unapproved uses or unsupported claims goes live without physician oversight tied to the FDA-approved label.
Every video recorded by a licensed physician against the approved label. No off-label language, no unsupported comparisons.
When patients engage with your education content, some will report side effects. Hoot captures those signals, organizes them against MedWatch reporting standards, and compiles the documentation needed for FDA submission, so no report falls through the cracks.
Under 21 CFR Part 314, any person, including a manufacturer’s contracted service provider, who becomes aware of information that reasonably suggests a serious adverse event must submit a report to the FDA within defined timeframes. This obligation does not disappear because the report came in through a text message reply.
Hoot’s platform flags patient responses that contain adverse event language, routes them to a pharmacovigilance review step, and compiles the structured report documentation required for FDA submission. Your medical affairs team reviews and approves before submission. Nothing is filed without your oversight.
This means your commercial team can run patient education campaigns at scale without building a separate intake process for every product, because Hoot carries that infrastructure for you.
Via SMS reply, email response, or in-app feedback, a patient describes a symptom or adverse experience after watching their education video.
The platform identifies adverse event language and classifies the report against MedWatch criteria: seriousness, causality, and reporting timeline.
Patient demographics, drug information, event description, and timing are organized into a structured package aligned with FDA Form 3500A reporting requirements.
The report is routed to your designated medical affairs contact for review, additions, and approval before any submission. Your team retains final authority.
Approved reports are submitted through MedWatch or the approved electronic gateway. Submission records, timestamps, and FDA acknowledgment receipts are stored and retrievable.
Hoot's MLR workflow is sequential, version-controlled, and designed to match how your review committee already operates, not to bypass it.
Script developed from approved label. Video recorded and transcribed.
Transcript, reference annotations, and ISI documentation submitted together.
Your committee reviews. Revisions tracked and resubmitted as needed.
Approval timestamp and approver record logged in the audit trail.
Campaign goes live. Deployment date and version locked in the record.
Before you bring a new vendor to your compliance review board, these are the answers to the questions they will ask.
Technical safeguards, administrative policies, and Business Associate Agreements with all subprocessors. All Protected Health Information handled under HIPAA standards at rest and in transit.
Independently audited against the SOC 2 Trust Service Criteria for security, availability, and confidentiality. Audit reports available to enterprise customers under NDA.
All patient data, communications, and analytics are stored and processed within US borders. No cross-border data transfers, no offshore subprocessors with access to PHI.
Every branded content piece goes through a structured MLR review before activation. Hoot does not deploy content that has not received documented approval from your review team.
Adverse event collection, classification, and reporting processes are aligned with 21 CFR Part 314 requirements. All reports are routed through your medical affairs team before submission.
Opt-in consent records, sender identification, and opt-out processing meet FTC and FCC standards for SMS and email communications. No outreach without documented patient consent.
Every certification, every workflow, and every policy described on this page is active today. When Hoot creates and delivers patient education on your behalf, these protections are in place for every campaign, every patient, and every product.
